Literature DB >> 10965021

Preparation and characterization of antibodies against human ribosomal proteins: heterogeneous expression of S11 and S30 in a panel of human cancer cell lines.

D Nadano1, G Ishihara, C Aoki, T Yoshinaka, S Irie, T A Sato.   

Abstract

Mutants of model eukaryotic organisms have revealed that most ribosomal proteins are essential for cell viability. However, the precise functional role of each ribosomal protein is largely unknown. Recent reports on the involvement of ribosomal proteins in various genetic diseases and studies on the extraribosomal functions of these proteins have cast some light on their localization and functions. Here we prepared rabbit polyclonal antibodies against 26 human ribosomal proteins; each of these reagents recognized a single band in immunoblots of the purified ribosome. We used these antibodies to evaluate a panel of human cancer cell lines. Although no deficiency of ribosomal proteins was observed, the abundance of S11 and S30 varied substantially among the cell lines, but the difference did not affect the biogenesis or composition of the ribosome. Therefore, the heterogeneity may be related to extraribosomal functions of S11 and S30. The antibodies described here are powerful tools for research into the molecular mechanisms of protein translation, cell-biological and medical studies on the ribosomal proteins, and ultimately a comprehensive understanding of all ribosomal proteins (rising dbl quote, left (low)ribosomics").

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965021      PMCID: PMC5926432          DOI: 10.1111/j.1349-7006.2000.tb01017.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  34 in total

1.  Ribosomal aggregate engaged in protein synthesis: characterization of the ergosome.

Authors:  F O WETTSTEIN; T STAEHELIN; H NOLL
Journal:  Nature       Date:  1963-02-02       Impact factor: 49.962

2.  p53 and the ribosomal protein L5 participate in high molecular mass complex formation with protein kinase CK2 in murine teratocarcinoma cell line F9 after serum stimulation and cisplatin treatment.

Authors:  B Guerra; O G Issinger
Journal:  FEBS Lett       Date:  1998-08-28       Impact factor: 4.124

3.  The GTPase center protein L12 is required for correct ribosomal stalk assembly but not for Saccharomyces cerevisiae viability.

Authors:  E Briones; C Briones; M Remacha; J P Ballesta
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

4.  Chromosomes of 14 hematopoietic cell lines derived from peripheral blood of persons with and without chromosome anomalies.

Authors:  C C Huang; G E Moore
Journal:  J Natl Cancer Inst       Date:  1969-11       Impact factor: 13.506

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  PKR: a new name and new roles.

Authors:  C G Proud
Journal:  Trends Biochem Sci       Date:  1995-06       Impact factor: 13.807

7.  Human ribosomal protein L7 inhibits cell-free translation in reticulocyte lysates and affects the expression of nuclear proteins upon stable transfection into Jurkat T-lymphoma cells.

Authors:  F Neumann; P Hemmerich; A von Mikecz; H H Peter; U Krawinkel
Journal:  Nucleic Acids Res       Date:  1995-01-25       Impact factor: 16.971

8.  fau cDNA encodes a ubiquitin-like-S30 fusion protein and is expressed as an antisense sequence in the Finkel-Biskis-Reilly murine sarcoma virus.

Authors:  L Michiels; E Van der Rauwelaert; F Van Hasselt; K Kas; J Merregaert
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

9.  Drosophila homolog of the human S6 ribosomal protein is required for tumor suppression in the hematopoietic system.

Authors:  K L Watson; K D Konrad; D F Woods; P J Bryant
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

10.  Monocyte chemotactic factor in rheumatoid arthritis synovial tissue. Probably a cross-linked derivative of S19 ribosomal protein.

Authors:  H Nishiura; Y Shibuya; S Matsubara; S Tanase; T Kambara; T Yamamoto
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

View more
  7 in total

Review 1.  Nuclear translation: what is the evidence?

Authors:  James E Dahlberg; Elsebet Lund; Elizabeth B Goodwin
Journal:  RNA       Date:  2003-01       Impact factor: 4.942

2.  Fibronectin controls cap-dependent translation through beta1 integrin and eukaryotic initiation factors 4 and 2 coordinated pathways.

Authors:  Chiara Gorrini; Fabrizio Loreni; Valentina Gandin; Leonardo A Sala; Nahum Sonenberg; Pier Carlo Marchisio; Stefano Biffo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-16       Impact factor: 11.205

3.  Regulation of alternative splicing within the supraspliceosome.

Authors:  Naama Sebbag-Sznajder; Oleg Raitskin; Minna Angenitzki; Taka-Aki Sato; Joseph Sperling; Ruth Sperling
Journal:  J Struct Biol       Date:  2011-11-12       Impact factor: 2.867

4.  Bystin in human cancer cells: intracellular localization and function in ribosome biogenesis.

Authors:  Masaya Miyoshi; Tetsuya Okajima; Tsukasa Matsuda; Michiko N Fukuda; Daita Nadano
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

5.  Ribosomal proteins and colorectal cancer.

Authors:  Mao-De Lai; Jing Xu
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

6.  Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation.

Authors:  Yaël Mamane; Emmanuel Petroulakis; Yvan Martineau; Taka-Aki Sato; Ola Larsson; Vinagolu K Rajasekhar; Nahum Sonenberg
Journal:  PLoS One       Date:  2007-02-21       Impact factor: 3.240

7.  Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinoma.

Authors:  Angela E Zou; Jonjei Ku; Thomas K Honda; Vicky Yu; Selena Z Kuo; Hao Zheng; Yinan Xuan; Maarouf A Saad; Andrew Hinton; Kevin T Brumund; Jonathan H Lin; Jessica Wang-Rodriguez; Weg M Ongkeko
Journal:  RNA       Date:  2015-04-22       Impact factor: 4.942

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.